Health
Sher ShayarIndia Ki Oncology Ka Naya Rang: Precision Medicine Ka Dhamaka!
Bhaiyon aur behno, India ki oncology ki duniya mein hai ek naya rang! Precision medicine ka chakkar hai, chemotherapy ki purani kahaniyan ab band! Nirali Shah keh rahe hain, 'Targeted therapies se badal raha hai khel, lung aur breast cancers ki taraf!' Servier ki vorasidenib aur Keytruda ka dhamaka, 2030 tak $9 billion ka bazaar! Aage ADCs aur bispecific antibodies ka jadoo hai, bhai!
few days ago | Anjali Singh
Quick rundown
1.India's oncology market is shifting towards precision medicine.
2.Regulatory approvals are expanding treatment options for high-incidence cancers.
3.Combination immunotherapies are improving patient outcomes.
4.India's first indigenous CAR-T cell therapy strengthens domestic innovation.
5.The oncology market in India is expected to nearly double by 2030.
